Sclerotherapy for esophageal varices

Area of Science:

• Gastroenterology
• Interventional Endoscopy

Background:

• Esophageal varices are a serious complication of portal hypertension.
• Bleeding from these varices can be life-threatening.

Purpose of the Study:

• To evaluate the efficacy of sclerotherapy as an early treatment for bleeding esophageal varices.
• To determine the role of sclerotherapy in managing acute variceal bleeding and as a bridge to definitive therapy.

Main Methods:

• Sclerotherapy involves injecting a sclerosant agent into or around esophageal varices.
• The procedure is typically performed endoscopically.
• Portacaval shunt is considered as a salvage therapy.

Main Results:

• Sclerotherapy is effective in the early management of bleeding esophageal varices.
• The procedure provides hemodynamic stability, allowing for further treatment decisions.
• Sclerotherapy exhibits a failure rate of up to 30%.

Conclusions:

• Sclerotherapy is a valuable tool for the initial treatment of bleeding esophageal varices.
• It can be safely performed without general anesthesia.
• Portacaval shunt is indicated for refractory cases of acute or long-term sclerotherapy failure.
• Prophylactic sclerotherapy is not advised.